课题基金 / 基金详情

Regulation of Extraocular Muscle Development

Regulation of Extraocular Muscle Development
眼外肌发育的调节
批准号:
7060809
负责人:
HENRY J KAMINSKI
金额:
$36.86万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-02-01 至 2008-01-31

项目摘要

项目成果

HENRY J KAMINSKI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Skeletal muscles are not all created equal. Muscle precursor cells or myoblasts are not a homogeneous population with a preordained fate, but rather represent distinct lineages derived from a variety of embryonic sources. Extrinsic factors interact with lineage in sculpting the molecular/cellular/structural traits of developing myofibers. The extraocular muscles (EOMs) are particularly unique among skeletal muscles. Our central hypothesis is that development of the novel EOM phenotype relies upon cell autonomous and non-cell autonomous regulatory mechanisms that are both shared with and strikingly divergent from those determining myoblast fates in other skeletal muscles. Specifically, we propose that neural interactions unique to the orbital environment and signaling cascades controlled by tissue-specific transcription factors direct EOM expression of a diverse array of EOM-specific, skeletal, and cardiac muscle traits that adapt it to the wide dynamic physiologic range required by eye movement control systems. A central problem is that the wealth of data from 'traditional' muscle studies is insufficient to explain the patterning and specification of distinctive EOM properties. Our recent expression profiling studies and development of an EOM cell line have provided the knowledge and tools to now identify and directly test EOM regulatory mechanisms. Specific Aim 1 will address cell autonomous regulatory mechanisms in EOM development, using immortialized EOM and hindlimb muscle cell lines in conjunction with gene/protein expression profiling. Specific Aim 2 will examine the role of the transcription factor, Pitx2, in regulating early and late features of EOM development. An allelic series of Pitx2 mutant mice will be used to determine dose dependence in regulation of both general and fiber type-specific traits. Specific Aim 3 will determine the role of a non-cell autonomous mechanism, unique to the orbital environment, in shaping EOM development. Our finding that EOM survival in organotypic co-culture is dependent upon oculomotor motoneuron innervation will be extended by assessing molecular specialization of EOM in culture with correct vs. incorrect motoneurons. The health relatedness of this proposal is that there is a clear need to understand the molecular specification of the EOM phenotype in order to comprehend both its unique functional features and differential responsiveness to metabolic and neuromuscular disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MGNet Administrative Core
  • 批准号:
    10437795
  • 项目类别:
  • 资助金额:
    $100.65万
  • 财政年份:
    2019
  • 负责人:
    HENRY J KAMINSKI
  • 依托单位:
Rare Disease Network for Myasthenia Gravis
  • 批准号:
    10207810
  • 项目类别:
  • 资助金额:
    $149.07万
  • 财政年份:
    2019
  • 负责人:
    HENRY J KAMINSKI
  • 依托单位:
Rare Disease Network for Myasthenia Gravis
  • 批准号:
    10437794
  • 项目类别:
  • 资助金额:
    $158.9万
  • 财政年份:
    2019
  • 负责人:
    HENRY J KAMINSKI
  • 依托单位:
An Open Label Trial of Ixazomib for Treatment Resistant Myasthenia Gravis
  • 批准号:
    10437798
  • 项目类别:
  • 资助金额:
    $24.72万
  • 财政年份:
    2019
  • 负责人:
    HENRY J KAMINSKI
  • 依托单位:
海外基金